转铁蛋白饱和度

结果治疗前静脉组与口服组间在男女性别比例、年龄、体重和接受治疗前维持透析时间及血红蛋白（Hb）、铁蛋白和转铁蛋白饱和度等方面均无显著差异。

Results There were no differences between intravenous and oral groups in sex , age , body weight , duration of hemodialysis , Hb values , ferritin and transferrin saturation before treatment .

检测不同处理组大鼠血清铁（SI）、总铁结合力（TIBC）、转铁蛋白饱和度（TS）及血清NO、一氧化氮合酶（NOS）水平。

Total iron binding capacity ( TIBC ), trans-ferrin saturation ( TS ), ferritin ( Fn ), nitric oxide ( NO ) and nitric oxide synthase ( NOS ) in the serum of rats treated with three different ways .

治疗前，两组患者男女性别比例、年龄、维持透析时间、血红蛋白（Hb）、红细胞比容（Hct）、铁蛋白（SP）和转铁蛋白饱和度（TSAT）等均无显著性差异。

There were no significant differences in the basic data ( gender , age , duration of hemodialysis , Hb , Hct , ferritin and transferring saturation , etc ) between two groups at pre-treatment .

方法对确诊ESRD的透析患者常规使用促红细胞生成素治疗贫血，分别以CHr和铁蛋白及转铁蛋白饱和度（TSAT）作为铁指标指导补铁，比较两组的疗效。

Methods CHr was used as iron indice as ferritin and transferring saturation ( TSAT ) in 57 ESRD dialysis patients using EPO for anemia , and the effects were compared .